Results 41 to 50 of about 1,200,470 (302)
A review of living donor liver transplantation: why is regeneration more rapid in the recipient compared to the donor? [PDF]
, 2009 Includes bibliographical references (leaves 54-62).Living donor liver transplantation (LDLT) is now well established and performed on a routine basis in many major centres around the world.
Sheriff B Ibirogba, Ibirogba, Sheriff B
core +1 more source
Stem Cell Research & Therapy, 2018 Background Mesenchymal stromal cells (MSCs) are promising cell therapy candidates. Clinical application is considered safe. However, minor side effects have included thromboembolism and instant blood-mediated inflammatory reactions suggesting an effect ...
P. Netsch +11 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
BMJ Global Health, 2019 Introduction The built environment defines opportunities for healthy eating and physical activity and may thus be related to blood lipids. The aim of this study is to systematically analyse the scientific evidence on associations between built ...
Rosa de Groot +5 more
doaj +1 more source
中西医结合护理, 2023 Objective To explore the effect IKAP health education model in nursing care of hematopoietic stem cell donors. Methods A total of 96 hematopoietic stem cell donors hospitalized in the hospital from June 2020 to September 2021 were selected and divided ...
ZONG Qiaosu (宗乔素)
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source
National Journal of Clinical Anatomy, 2020 Background and Aim: Medical institutes around the world are facing scarcity of cadavers for anatomy dissection and teaching purpose. The academic value of “hands-on experience” on human bodies remains the mainstay of medical education, especially in the ...
Abu Ubaida Siddiqui +4 more
doaj +1 more source
Theoretical model of donor–donor and donor–acceptor energy transfer on a nanosphere
Scientific ReportsAbstractIn this study, we introduce a novel advancement in the field of theoretical exploration. Specifically, we investigate the transfer and trapping of electronic excitations within a two-component disordered system confined to a finite volume.
Anna Synak +2 more
openaire +3 more sources
Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari +5 more
wiley +1 more source